- Home
- LSF vs GNTA Comparison
LSF vs GNTA Comparison
Compare LSF & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSF
- GNTA
- Stock Information
- Founded
- LSF 2015
- GNTA 2014
- Country
- LSF United States
- GNTA Italy
- Employees
- LSF N/A
- GNTA N/A
- Industry
- LSF Packaged Foods
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LSF Consumer Staples
- GNTA Health Care
- Exchange
- LSF Nasdaq
- GNTA Nasdaq
- Market Cap
- LSF 61.6M
- GNTA 62.9M
- IPO Year
- LSF 2020
- GNTA 2021
- Fundamental
- Price
- LSF $5.64
- GNTA $3.05
- Analyst Decision
- LSF Strong Buy
- GNTA Strong Buy
- Analyst Count
- LSF 2
- GNTA 1
- Target Price
- LSF $12.00
- GNTA $25.00
- AVG Volume (30 Days)
- LSF 33.5K
- GNTA 16.9K
- Earning Date
- LSF 11-05-2025
- GNTA 01-01-0001
- Dividend Yield
- LSF N/A
- GNTA N/A
- EPS Growth
- LSF N/A
- GNTA N/A
- EPS
- LSF N/A
- GNTA N/A
- Revenue
- LSF $47,027,546.00
- GNTA N/A
- Revenue This Year
- LSF $21.88
- GNTA N/A
- Revenue Next Year
- LSF $20.86
- GNTA N/A
- P/E Ratio
- LSF N/A
- GNTA N/A
- Revenue Growth
- LSF 22.79
- GNTA N/A
- 52 Week Low
- LSF $3.60
- GNTA $2.56
- 52 Week High
- LSF $10.90
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- LSF 40.11
- GNTA 48.77
- Support Level
- LSF $5.68
- GNTA N/A
- Resistance Level
- LSF $5.99
- GNTA $3.69
- Average True Range (ATR)
- LSF 0.23
- GNTA 0.29
- MACD
- LSF 0.03
- GNTA -0.17
- Stochastic Oscillator
- LSF 7.52
- GNTA 67.67
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.